Koenraad Jozef Lodewijk Marcel Andries
37Patents
7h-index
48Co-inventors
69Inventor score
Filing activity: Jun 23, 1988 → Dec 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6197779A | HIV inhibiting pyrimidine derivative | Chemistry; Metallurgy | 111 | Expired |
| US6440986B2 | HIV Inhibiting pyrimidine derivatives | Chemistry; Metallurgy | 50 | Expired |
| US4956351A | Antiviral pharmaceutical compositions containing cyclodextrins | Performing Operations; Transporting | 44 | Expired |
| US7361657B2 | Respiratory syncytial virus replication inhibitors | Chemistry; Metallurgy | 14 | Expired |
| US8017606B2 | Quinoline derivatives as antibacterial agents | Emerging Cross-Sectional Technologies | 13 | Active |
| US6924287B1 | Respiratory syncytial virus replication inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US8530655B2 | HIV replication inhibiting pyrimidines | Human Necessities | 9 | Active |
| US6747028B1 | Respiratory syncytial virus replication inhibitors | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7179811B2 | Respiratory syncytial virus replication inhibitors | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7449463B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 4 | Expired |
| US7071192B1 | Respiratory syncytial virus replication inhibitors | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6903213B2 | HIV inhibiting pyrimidine derivatives | Chemistry; Metallurgy | 3 | Expired |
| US8415475B2 | Antibacterial quinoline derivatives | Chemistry; Metallurgy | 3 | Active |
| US8026248B2 | HIV inhibiting pyrimidine derivatives | Chemistry; Metallurgy | 3 | Active |
| US7709498B2 | Quinoline derivatives as antibacterial agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US7173034B2 | Respiratory syncytial virus replication inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US7998979B2 | Antibacterial quinoline derivatives | Human Necessities | 1 | Active |
| US8293732B2 | Antibacterial quinoline derivatives | Chemistry; Metallurgy | 1 | Active |
| US7173054B2 | Respiratory syncytial virus replication inhibitors | Chemistry; Metallurgy | 1 | Expired |
| US7407969B2 | Respiratory syncytial virus replication inhibitors | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8691800B2 | Quinoline derivatives as antibacterial agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US10508097B2 | Antibacterial compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11918575B2 | PZA and cytochrome Bc1 inhibitor combination treatment | Human Necessities | 0 | Active |
| US11141384B2 | Long-acting formulations | Performing Operations; Transporting | 0 | Active |
| US8044073B2 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.